TORPEDO Study: A Study on Rapid Effect of Tocilizumab in Patients With Rheumatoid Arthritis With an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) or Anti-TNF
Clinical trial NCT00977106 · COMPLETED
Trial details
- NCT number
- NCT00977106
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2011-10-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.